{"id":418728,"date":"2021-01-21T09:03:40","date_gmt":"2021-01-21T14:03:40","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=418728"},"modified":"2021-01-21T09:03:40","modified_gmt":"2021-01-21T14:03:40","slug":"goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/","title":{"rendered":"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">PHILADELPHIA<\/span>, <span class=\"xn-chron\">Jan. 21, 2021<\/span> \/PRNewswire\/ &#8212; <span class=\"xn-person\">Berger Montague<\/span> is investigating potential securities fraud claims against GoodRx Holdings, Inc. (&#8220;GoodRx&#8221; or the &#8220;Company&#8221;) on behalf of investors who purchased GoodRx securities (NASDAQ: GDRX) between <b><span class=\"xn-chron\">September 23, 2020<\/span> and <span class=\"xn-chron\">November 16, 2020<\/span><\/b> (the &#8220;Class Period&#8221;). <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg\" title=\"A national class action and commercial litigation law firm with nationally known attorneys highly sought after for their legal skills. (PRNewsFoto\/Berger Montague)\" alt=\"A national class action and commercial litigation law firm with nationally known attorneys highly sought after for their legal skills. (PRNewsFoto\/Berger Montague)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>If you purchased GoodRx securities during the Class Period, have questions concerning your rights or interests, or would like to discuss <span class=\"xn-person\">Berger Montague&#8217;s<\/span> investigation, please contact attorneys <span class=\"xn-person\">Andrew Abramowitz<\/span> at <a target=\"_blank\" href=\"mailto:aabramowitz@bm.net\" rel=\"nofollow noopener noreferrer\">aabramowitz@bm.net<\/a>\u00a0or (215) 875-3015, or <span class=\"xn-person\">Donnell Much<\/span> at <a target=\"_blank\" href=\"mailto:dmuch@bm.net\" rel=\"nofollow noopener noreferrer\">dmuch@bm.net<\/a>\u00a0or (215) 875-4667, or contact us at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3042984-1&amp;h=318766596&amp;u=http%3A%2F%2Fwww.bergermontague.com%2Fgoodrx&amp;a=www.bergermontague.com%2Fgoodrx\" rel=\"nofollow noopener noreferrer\">www.bergermontague.com\/goodrx<\/a>. <\/p>\n<p>According to a recently filed lawsuit, throughout the Class Period GoodRx and members of its senior management deceived investors by failing to disclose that at the time of the Company&#8217;s IPO in <span class=\"xn-chron\">September 2020<\/span>, Amazon.com, Inc. was preparing to launch its own mobile prescription fulfillment service that would directly compete with GoodRx. The suit accuses the Company of timing the IPO so that it was priced before Amazon announced its online pharmaceutical business, which the Company and the selling shareholders knew would adversely impact the price of GoodRx&#8217;s stock. Furthermore, the complaint alleges that when speaking to investors about GoodRx&#8217;s competitive environment, defendants specifically failed to mention Amazon&#8217;s imminent entry into the mobile prescription app space. <\/p>\n<p>On <span class=\"xn-chron\">November 17, 2020<\/span>, when Amazon announced two new pharmacy offerings that would compete with GoodRx, Company shares plummeted <span class=\"xn-money\">$10.51<\/span> per share \u2013 or 23% \u2013 from <span class=\"xn-money\">$46.72<\/span> per share to <span class=\"xn-money\">$36.21<\/span> over the course of a single trading day. <\/p>\n<p>If you purchased GoodRx securities during the Class Period, you may seek Court appointment as lead plaintiff to represent other injured investors in a class action. The lead plaintiff appointment deadline is <b><span class=\"xn-chron\">February 16, 2021<\/span>.<\/b> You do not need to be a lead plaintiff to share in any potential Class recovery.<\/p>\n<p>\n        <b>Whistleblowers:\u00a0<\/b>Persons with non-public information regarding GoodRx are encouraged to confidentially assist <span class=\"xn-person\">Berger Montague&#8217;s<\/span> investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.<\/p>\n<p>\n        <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3042984-1&amp;h=2166241810&amp;u=https%3A%2F%2Fbergermontague.com%2F&amp;a=Berger+Montague\" rel=\"nofollow noopener noreferrer\"><br \/>\n          <span class=\"xn-person\">Berger Montague<\/span><br \/>\n        <\/a>, with offices in <span class=\"xn-location\">Philadelphia<\/span>, <span class=\"xn-location\">Minneapolis<\/span>, <span class=\"xn-location\">Washington, D.C.<\/span>, and <span class=\"xn-location\">San Diego<\/span>, has been a pioneer in securities class action litigation since its founding in 1970. <span class=\"xn-person\">Berger Montague<\/span> has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout <span class=\"xn-location\">the United States<\/span>.<\/p>\n<p>\n        <b>Contacts:<\/b>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Andrew Abramowitz<\/span>, Senior Counsel <br \/><span class=\"xn-person\">Berger Montague<\/span><br \/>(215) 875-3015 <br \/><a target=\"_blank\" href=\"mailto:aabramowitz@bm.net\" rel=\"nofollow noopener noreferrer\">aabramowitz@bm.net<\/a>\u00a0\u00a0<\/p>\n<p>\n        <span class=\"xn-person\">Donnell Much<\/span>, Associate <br \/><span class=\"xn-person\">Berger Montague<\/span><br \/>(215) 875-4667 <br \/><a target=\"_blank\" href=\"mailto:dmuch@bm.net\" rel=\"nofollow noopener noreferrer\">dmuch@bm.net<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC54583&amp;sd=2021-01-21\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-301212222.html\">http:\/\/www.prnewswire.com\/news-releases\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-301212222.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Berger Montague<\/span><\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC54583&amp;Transmission_Id=202101210900PR_NEWS_USPR_____DC54583&amp;DateId=20210121\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire PHILADELPHIA, Jan. 21, 2021 \/PRNewswire\/ &#8212; Berger Montague is investigating potential securities fraud claims against GoodRx Holdings, Inc. (&#8220;GoodRx&#8221; or the &#8220;Company&#8221;) on behalf of investors who purchased GoodRx securities (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020 (the &#8220;Class Period&#8221;). If you purchased GoodRx securities during the Class Period, have questions concerning your rights or interests, or would like to discuss Berger Montague&#8217;s investigation, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net\u00a0or (215) 875-3015, or Donnell Much at dmuch@bm.net\u00a0or (215) 875-4667, or contact us at www.bergermontague.com\/goodrx. According to a recently filed lawsuit, throughout the Class Period GoodRx and members of its senior management deceived investors by failing to disclose that at the time of the Company&#8217;s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-418728","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PHILADELPHIA, Jan. 21, 2021 \/PRNewswire\/ &#8212; Berger Montague is investigating potential securities fraud claims against GoodRx Holdings, Inc. (&#8220;GoodRx&#8221; or the &#8220;Company&#8221;) on behalf of investors who purchased GoodRx securities (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020 (the &#8220;Class Period&#8221;). If you purchased GoodRx securities during the Class Period, have questions concerning your rights or interests, or would like to discuss Berger Montague&#8217;s investigation, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net\u00a0or (215) 875-3015, or Donnell Much at dmuch@bm.net\u00a0or (215) 875-4667, or contact us at www.bergermontague.com\/goodrx. According to a recently filed lawsuit, throughout the Class Period GoodRx and members of its senior management deceived investors by failing to disclose that at the time of the Company&#8217;s &hellip; Continue reading &quot;GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-21T14:03:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021\",\"datePublished\":\"2021-01-21T14:03:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/\"},\"wordCount\":445,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/\",\"name\":\"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"datePublished\":\"2021-01-21T14:03:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/","og_locale":"en_US","og_type":"article","og_title":"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021 - Market Newsdesk","og_description":"PR Newswire PHILADELPHIA, Jan. 21, 2021 \/PRNewswire\/ &#8212; Berger Montague is investigating potential securities fraud claims against GoodRx Holdings, Inc. (&#8220;GoodRx&#8221; or the &#8220;Company&#8221;) on behalf of investors who purchased GoodRx securities (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020 (the &#8220;Class Period&#8221;). If you purchased GoodRx securities during the Class Period, have questions concerning your rights or interests, or would like to discuss Berger Montague&#8217;s investigation, please contact attorneys Andrew Abramowitz at aabramowitz@bm.net\u00a0or (215) 875-3015, or Donnell Much at dmuch@bm.net\u00a0or (215) 875-4667, or contact us at www.bergermontague.com\/goodrx. According to a recently filed lawsuit, throughout the Class Period GoodRx and members of its senior management deceived investors by failing to disclose that at the time of the Company&#8217;s &hellip; Continue reading \"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-21T14:03:40+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021","datePublished":"2021-01-21T14:03:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/"},"wordCount":445,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/","name":"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","datePublished":"2021-01-21T14:03:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-stock-berger-montague-investigates-alleged-securities-fraud-claims-against-goodrx-holdings-inc-nasdaq-gdrx-lead-plaintiff-deadline-is-february-16-2021-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/418728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=418728"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/418728\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=418728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=418728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=418728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}